Cargando…

Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy

BACKGROUND AND AIM: Controlling the risk factors was the most effective strategy to prevent diabetic retinopathy (DR). This study aimed to recognize the risk factors of DR, and explores whether the effect of those factors is modified by diabetes mellitus (DM) duration. METHODS: A total of 1058 DM pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jianting, Dong, Zhenhua, Wang, Xiaoli, Wang, Xin, Wang, Lulu, Pang, Shuguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493150/
https://www.ncbi.nlm.nih.gov/pubmed/37700740
http://dx.doi.org/10.2147/IJGM.S420983
_version_ 1785104414744248320
author Li, Jianting
Dong, Zhenhua
Wang, Xiaoli
Wang, Xin
Wang, Lulu
Pang, Shuguang
author_facet Li, Jianting
Dong, Zhenhua
Wang, Xiaoli
Wang, Xin
Wang, Lulu
Pang, Shuguang
author_sort Li, Jianting
collection PubMed
description BACKGROUND AND AIM: Controlling the risk factors was the most effective strategy to prevent diabetic retinopathy (DR). This study aimed to recognize the risk factors of DR, and explores whether the effect of those factors is modified by diabetes mellitus (DM) duration. METHODS: A total of 1058 DM patients with information about DR assessment were included. DR was measured by a complete ophthalmic examination and was classified as having one or more distinct microaneurysms in the eyes. Data from the lab and clinical factors were gathered. Multivariate logistic analysis was used to examine the risk factors, and the best-fitting model was selected by a backward stepwise based on A1C. RESULTS: In the current study, 274 (25.9%) patients developed DR. In the entire subjects, baseline age, the level of C-peptide, and urinary creatinine were all presented as protective effects of DR, whose odds ratios (ORs) and 95% confidence intervals (CIs) were 0.79 (0.62, 0.99), 0.75 (0.61, 0.91), and 0.70 (0.52, 0.93), respectively. Conversely, systolic pressure (SBP), urinary albumin, and BUN/Cr ratio were the important risk factors for DR with ORs (95% CIs) 1.21 (1.01, 1.46), 1.55 (1.30, 1.84), and 1.33 (1.11, 1.59), respectively. In stratification analysis, females with higher SBP would be more likely to develop DR in the short-duration group, while C-peptide and urinary creatinine showed protective effects in the long-duration group. BUN/Cr ratio all presented as a risk factor, with ORs 1.38 (p = 0.041) and 1.33 (p = 0.014) in short- and long-duration groups, respectively. CONCLUSION: Although renal functions presented a significant association with DR in all DM patients, the risk factors of DR varied widely in different disease-duration subjects. Target strategies to prevent DR should be put forward individually, considering the patient’s DM duration. Improving the BUN/Cr ratio may be beneficial to delaying DR.
format Online
Article
Text
id pubmed-10493150
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-104931502023-09-11 Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy Li, Jianting Dong, Zhenhua Wang, Xiaoli Wang, Xin Wang, Lulu Pang, Shuguang Int J Gen Med Original Research BACKGROUND AND AIM: Controlling the risk factors was the most effective strategy to prevent diabetic retinopathy (DR). This study aimed to recognize the risk factors of DR, and explores whether the effect of those factors is modified by diabetes mellitus (DM) duration. METHODS: A total of 1058 DM patients with information about DR assessment were included. DR was measured by a complete ophthalmic examination and was classified as having one or more distinct microaneurysms in the eyes. Data from the lab and clinical factors were gathered. Multivariate logistic analysis was used to examine the risk factors, and the best-fitting model was selected by a backward stepwise based on A1C. RESULTS: In the current study, 274 (25.9%) patients developed DR. In the entire subjects, baseline age, the level of C-peptide, and urinary creatinine were all presented as protective effects of DR, whose odds ratios (ORs) and 95% confidence intervals (CIs) were 0.79 (0.62, 0.99), 0.75 (0.61, 0.91), and 0.70 (0.52, 0.93), respectively. Conversely, systolic pressure (SBP), urinary albumin, and BUN/Cr ratio were the important risk factors for DR with ORs (95% CIs) 1.21 (1.01, 1.46), 1.55 (1.30, 1.84), and 1.33 (1.11, 1.59), respectively. In stratification analysis, females with higher SBP would be more likely to develop DR in the short-duration group, while C-peptide and urinary creatinine showed protective effects in the long-duration group. BUN/Cr ratio all presented as a risk factor, with ORs 1.38 (p = 0.041) and 1.33 (p = 0.014) in short- and long-duration groups, respectively. CONCLUSION: Although renal functions presented a significant association with DR in all DM patients, the risk factors of DR varied widely in different disease-duration subjects. Target strategies to prevent DR should be put forward individually, considering the patient’s DM duration. Improving the BUN/Cr ratio may be beneficial to delaying DR. Dove 2023-09-06 /pmc/articles/PMC10493150/ /pubmed/37700740 http://dx.doi.org/10.2147/IJGM.S420983 Text en © 2023 Li et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Li, Jianting
Dong, Zhenhua
Wang, Xiaoli
Wang, Xin
Wang, Lulu
Pang, Shuguang
Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy
title Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy
title_full Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy
title_fullStr Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy
title_full_unstemmed Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy
title_short Risk Factors for Diabetic Retinopathy in Chinese Patients with Different Diabetes Duration: Association of C-Peptide and BUN/Cr Ratio with Type 2 Diabetic Retinopathy
title_sort risk factors for diabetic retinopathy in chinese patients with different diabetes duration: association of c-peptide and bun/cr ratio with type 2 diabetic retinopathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493150/
https://www.ncbi.nlm.nih.gov/pubmed/37700740
http://dx.doi.org/10.2147/IJGM.S420983
work_keys_str_mv AT lijianting riskfactorsfordiabeticretinopathyinchinesepatientswithdifferentdiabetesdurationassociationofcpeptideandbuncrratiowithtype2diabeticretinopathy
AT dongzhenhua riskfactorsfordiabeticretinopathyinchinesepatientswithdifferentdiabetesdurationassociationofcpeptideandbuncrratiowithtype2diabeticretinopathy
AT wangxiaoli riskfactorsfordiabeticretinopathyinchinesepatientswithdifferentdiabetesdurationassociationofcpeptideandbuncrratiowithtype2diabeticretinopathy
AT wangxin riskfactorsfordiabeticretinopathyinchinesepatientswithdifferentdiabetesdurationassociationofcpeptideandbuncrratiowithtype2diabeticretinopathy
AT wanglulu riskfactorsfordiabeticretinopathyinchinesepatientswithdifferentdiabetesdurationassociationofcpeptideandbuncrratiowithtype2diabeticretinopathy
AT pangshuguang riskfactorsfordiabeticretinopathyinchinesepatientswithdifferentdiabetesdurationassociationofcpeptideandbuncrratiowithtype2diabeticretinopathy